Literature DB >> 15985554

A tumor necrosis factor receptor family protein serves as a cellular receptor for the macrophage-tropic equine lentivirus.

Baoshan Zhang1, Sha Jin, Jing Jin, Feng Li, Ronald C Montelaro.   

Abstract

Characterization of cellular receptors for human, simian, and feline immunodeficiency viruses that are tropic for lymphocytes and macrophages have revealed a common theme of a sequential binding of viral envelope proteins with two coreceptors to mediate virus infection of target cells. In contrast to these dual tropic immunodeficiency viruses, the ungulate lentiviruses, including equine infectious anemia virus (EIAV), exclusively infect cells of the monocyte-macrophage lineage to cause progressive degenerative diseases without clinical immunodeficiency. EIAV causes a uniquely dynamic disease that is characterized by recurrent disease episodes including fever, diarrhea, lethargy, anemia, and thrombocytopenia. Although EIAV provides an important animal model for lentivirus disease resulting from macrophage infection, to date there has been no definition of the specific cellular receptor(s) used by the equine lentivirus to infect target cells. In the current study, we have identified and cloned a functional receptor for EIAV, designated equine lentivirus receptor-1 (ELR1), related to the family of TNF receptor (TNFR) proteins. ELR1 was shown to be expressed in various equine cells permissive for EIAV replication in vitro, including monocytes and macrophages. In contrast, EIAV-resistant human, murine, and simian cells were negative for ELR1 expression but became susceptible to virus infection when transduced with a recombinant murine retrovirus expressing the ELR1. Thus, these results identify a specific functional receptor for a macrophagetropic lentivirus and indicate that infection by EIAV may be mediated by a single receptor, in contrast to coreceptors used by the lymphotropic immunodeficiency lentiviruses.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15985554      PMCID: PMC1174982          DOI: 10.1073/pnas.0501560102

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  27 in total

1.  Cell-dependent mechanisms restrict the HIV type 1 coreceptor activity of US28, a chemokine receptor homolog encoded by human cytomegalovirus.

Authors:  A Ohagen; L Li; A Rosenzweig; D Gabuzda
Journal:  AIDS Res Hum Retroviruses       Date:  2000-01-01       Impact factor: 2.205

Review 2.  The TNF and TNF receptor superfamilies: integrating mammalian biology.

Authors:  R M Locksley; N Killeen; M J Lenardo
Journal:  Cell       Date:  2001-02-23       Impact factor: 41.582

3.  Characterization of a cytolytic strain of equine infectious anemia virus.

Authors:  Wendy Maury; Patrick J Wright; Sarahann Bradley
Journal:  J Virol       Date:  2003-02       Impact factor: 5.103

4.  Differential responses of Equus caballus and Equus asinus to infection with two pathogenic strains of equine infectious anemia virus.

Authors:  S J Cook; R F Cook; R C Montelaro; C J Issel
Journal:  Vet Microbiol       Date:  2001-03-20       Impact factor: 3.293

5.  Involvement of clathrin-mediated endocytosis in human immunodeficiency virus type 1 entry.

Authors:  Jessica Daecke; Oliver T Fackler; Matthias T Dittmar; Hans-Georg Kräusslich
Journal:  J Virol       Date:  2005-02       Impact factor: 5.103

6.  DH82 cells: a macrophage cell line for the replication and study of equine infectious anemia virus.

Authors:  R Hines; W Maury
Journal:  J Virol Methods       Date:  2001-06       Impact factor: 2.014

7.  Endocytosis is a critical step in entry of subgroup B avian leukosis viruses.

Authors:  Felipe Diaz-Griffero; Steven Ari Hoschander; Jürgen Brojatsch
Journal:  J Virol       Date:  2002-12       Impact factor: 5.103

8.  Identification and characterization of a shared TNFR-related receptor for subgroup B, D, and E avian leukosis viruses reveal cysteine residues required specifically for subgroup E viral entry.

Authors:  H B Adkins; J Brojatsch; J A Young
Journal:  J Virol       Date:  2000-04       Impact factor: 5.103

9.  Expression of IFN-gamma induced CXCR3 agonist chemokines and compartmentalization of CXCR3+ cells in the periphery and lymph nodes of rhesus macaques during simian immunodeficiency virus infection and acquired immunodeficiency syndrome.

Authors:  Surojit Sarkar; Vandana Kalia; Michael Murphey-Corb; Ronald C Montelaro; Todd A Reinhart
Journal:  J Med Primatol       Date:  2003-08       Impact factor: 0.667

Review 10.  Cell surface receptors, virus entry and tropism of primate lentiviruses.

Authors:  Paul R Clapham; Áine McKnight
Journal:  J Gen Virol       Date:  2002-08       Impact factor: 3.891

View more
  24 in total

1.  Equine viperin restricts equine infectious anemia virus replication by inhibiting the production and/or release of viral Gag, Env, and receptor via distortion of the endoplasmic reticulum.

Authors:  Yan-Dong Tang; Lei Na; Chun-Hui Zhu; Nan Shen; Fei Yang; Xian-Qiu Fu; Yu-Hong Wang; Li-Hua Fu; Jia-Yi Wang; Yue-Zhi Lin; Xue-Feng Wang; Xiaojun Wang; Jian-Hua Zhou; Cheng-Yao Li
Journal:  J Virol       Date:  2014-08-13       Impact factor: 5.103

2.  Immune suppression of challenged vaccinates as a rigorous assessment of sterile protection by lentiviral vaccines.

Authors:  Jodi K Craigo; Shannon Durkin; Timothy J Sturgeon; Tara Tagmyer; Sheila J Cook; Charles J Issel; Ronald C Montelaro
Journal:  Vaccine       Date:  2006-09-22       Impact factor: 3.641

3.  Na+/H+ exchanger type 1 is a receptor for pathogenic subgroup J avian leukosis virus.

Authors:  Ning Chai; Paul Bates
Journal:  Proc Natl Acad Sci U S A       Date:  2006-03-27       Impact factor: 11.205

4.  Selection of a rare neutralization-resistant variant following passive transfer of convalescent immune plasma in equine infectious anemia virus-challenged SCID horses.

Authors:  Sandra D Taylor; Steven R Leib; Susan Carpenter; Robert H Mealey
Journal:  J Virol       Date:  2010-04-14       Impact factor: 5.103

5.  Endocytosis and a low-pH step are required for productive entry of equine infectious anemia virus.

Authors:  Melinda A Brindley; Wendy Maury
Journal:  J Virol       Date:  2005-12       Impact factor: 5.103

6.  Replication of equine infectious anemia virus in engineered mouse NIH 3T3 cells.

Authors:  Baoshan Zhang; Ronald C Montelaro
Journal:  J Virol       Date:  2008-12-10       Impact factor: 5.103

7.  An equine infectious anemia virus variant superinfects cells through novel receptor interactions.

Authors:  Melinda A Brindley; Baoshan Zhang; Ronald C Montelaro; Wendy Maury
Journal:  J Virol       Date:  2008-07-30       Impact factor: 5.103

8.  Evolutionary study of leporid CD4 reveals a hotspot of genetic variability within the D2 domain.

Authors:  Patricia de Sousa-Pereira; Joana Abrantes; Hanna-Mari Baldauf; Oliver T Keppler; Pedro J Esteves
Journal:  Immunogenetics       Date:  2016-03-15       Impact factor: 2.846

9.  Restriction of equine infectious anemia virus by equine APOBEC3 cytidine deaminases.

Authors:  Jörg Zielonka; Ignacio G Bravo; Daniela Marino; Elea Conrad; Mario Perković; Marion Battenberg; Klaus Cichutek; Carsten Münk
Journal:  J Virol       Date:  2009-05-20       Impact factor: 5.103

10.  Mapping of equine lentivirus receptor 1 residues critical for equine infectious anemia virus envelope binding.

Authors:  Baoshan Zhang; Chengqun Sun; Sha Jin; Michael Cascio; Ronald C Montelaro
Journal:  J Virol       Date:  2007-11-21       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.